Loading
Loading
Supernus Pharmaceuticals ceo salary
Jack A. Khattar, Chief Executive Officer President & Secretary of SUPERNUS PHARMACEUTICALS, INC. (SUPN), received $15,501,557 ($15.5M) in total compensation for FY2025, down 13.1% from the prior year. Option awards of $7,031,545 were the largest component. Figures come from SUPERNUS PHARMACEUTICALS, INC.'s DEF 14A filed 30 Apr 2026 (accession 0001104659-26-053111).
Reported total from the latest DEF 14A pay table. Source filing (accession 0001104659-26-053111). These figures come from SUPERNUS PHARMACEUTICALS, INC.'s DEF 14A filed 30 Apr 2026 (accession 0001104659-26-053111).
| Component | Amount |
|---|---|
| Salary | $1,036,000 |
| Stock awards | $6,535,029 |
| Option awards | $7,031,545 |
| Cash incentive | $846,930 |
| Other | $52,053 |
| Total | $15,501,557 |
FAQ
See also: SUPN ticker page